ArticleIn vivo (Athens, Greece)

Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft.

Michael A Turner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.